Cipherome has a total of 44 patents globally, out of which 23 have been granted. Of these 44 patents, more than 65% patents are active. The USA is where Cipherome has filed the maximum number of patents, followed by South Korea. Parallelly, South Korea seems to be the main focused
Life365 has a total of 11 patents globally, out of which 9 have been granted. Of these 11 patents, more than 90% patents are active. The United States of America is where Life365 has filed all the number of patents. Parallelly, the United States of America seems to be the
Nacuity Pharmaceuticals has a total of 94 patents globally, out of which 25 have been granted. Of these 94 patents, more than 75% patents are active. The USA is where Nacuity Pharmaceuticals has filed the maximum number of patents, followed by Australia and Europe (EPO). Parallelly, the USA seems to
Rivus Pharmaceuticals has a total of 45 patents globally, out of which 25 have been granted. Of these 45 patents, more than 95% patents are active. The USA is where Rivus Pharmaceuticals has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, the United States seems
Woolsey Pharmaceuticals has a total of 59 patents globally, out of which 4 have been granted. Of these 59 patents, more than 98% patents are active. The USA is where Woolsey Pharmaceuticals has filed the maximum number of patents, followed by Europe (EPO) and Canada. Parallelly, the United States seems
Obsidian Therapeutics has a total of 127 patents globally, out of which 7 have been granted. Of these 127 patents, more than 81% patents are active. The USA is where Obsidian Therapeutics has filed the maximum number of patents, followed by Europe (EPO) and Hong Kong. Parallelly, the US seems
Philter Labs has a total of 39 patents globally, out of which 12 have been granted. Of these 39 patents, more than 92% patents are active. The United States is where Philter Labs has filed the maximum number of patents. Parallelly, the USA seems to be the main focused R&D
Mymee has a total of 11 patents globally, out of which 6 have been granted. Of these 11 patents, more than 90% patents are active. The USA is where Mymee has filed the maximum number of patents. Parallelly, the United States seems to be the main focused R&D center of
Diagnose Early has a total of 15 patents globally, out of which 2 have been granted. Of these 15 patents, more than 86% patents are active. The USA is where Diagnose Early has filed the maximum number of patents, followed by Canada & Europe (EPO). Parallelly, the United States seems
Canopy Biosciences has a total of 24 patents globally, out of which 9 have been granted. Of these 24 patents, more than 87% patents are active. Europe (EPO) is where Canopy Biosciences has filed the maximum number of patents, followed by United States of America. Parallelly, Italy & Austria seems
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.